A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Conditions:   Chronic Kidney Disease;   Chronic Renal FailureInterventions:   Biological: Epoetin Hospira;   Biological: Epogen (Amgen)Sponsor:   Hospira, Inc.Completed - verified April 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials